Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A shortage of Kayexalate leads to an ER visit

Hans Duvefelt, MD
Meds
February 21, 2019
Share
Tweet
Share

Last week I had a patient with mild kidney disease and a high potassium. I thought that it would be easy to take care of. We called around to all the pharmacies from Bangor to Ellsworth to Belfast, and nobody had Kayexalate, the time-tested antidote, in stock.

It happened to be on a Tuesday night with my Suboxone group starting at 5 o’clock. The patient had been there since 4; his labs were available by 4:30.

It was 4:45 and we were almost done calling around to pharmacies. I had Autumn, my medical assistant, make some of the calls. Fifteen minutes left before clinic with 14 patients to see in 90 minutes (we pull them out from group therapy to check in and renew their scripts). And I had a new patient, an internal transfer but still new to me, with multiple medical problems to see before clinic.

I did what I hardly ever do: I asked Autumn to call the emergency room on my behalf and tell them that we had no choice but to send the patient over. We faxed records and lab reports, and I moved on.

The ER doctor’s report was scathing. He clearly thought I had dumped on him. He didn’t do what I had thought he might do.

I hadn’t done it since I stopped doing hospital medicine a generation ago, but I know you could hydrate him to help his mild acute kidney injury and coadminister glucose and insulin to lower the potassium at the same time.

Instead, the emergency room doctor gave him Kayexalate, because the hospital had it in stock. He probably didn’t know that wasn’t an option for us. I looked like an idiot to him, but that often happens in primary care.

I had gotten over my frustration and embarrassment when, this week, I had a patient on warfarin with a supratherapeutic INR and no active bleeding. I’ve never been nervous about those situations but this was a high number, and Up-To-Date suggested vitamin K, orally because it works faster than injectable, while obviously holding the warfarin. So, guess what, we called every pharmacy from Bangor to Ellsworth to Belfast, and nobody had vitamin K in stock. The Natural Living Center in Bangor had a very low potency supplement where maybe 50 pills would be enough of a dose to make a difference.

One of the hospital pharmacists was available to talk to me and explained that a small bottle of vitamin K in the potency required to reverse warfarin costs about $1,000 and neither hospitals nor pharmacies want to stock them because they will lose so much money if the drug expires. What the hospitals do instead is compound an oral form from the injectable that is still expensive but less so. But a hospital can’t sell or administer to an outpatient whose primary care physician does not have privileges at that hospital. I technically have privileges at Cary Medical Center in Caribou, but that’s 200 miles north.

So this was a judgment call: Send the patient to the emergency room so she can incur the emergency room fee and have them give her an oral medication that may or may not make a difference since she had no active bleeding. Or I could bubble wrap her for a couple of days while the warfarin effect wore off.

Today, in Van Buren, I called the small local Rexall (a historical U.S. pharmacy name) and chatted with the owner, John Hebert. He has Kayexalate in stock. This is in a town of 2,000 people. From Bangor to Ellsworth to Belfast I imagine there are 100,000 people. They don’t have outpatient access to this drug.

It’s a sad situation when potentially life-saving medications are unavailable because pharmacies don’t want to risk having them expire and go on unsold. We have automatic defibrillators in schools and shopping malls; why not some basic antidotes available, maybe even subsidized, in strategically located pharmacies?

Hans Duvefelt, also known as “A Country Doctor,” is a family physician who blogs at A Country Doctor Writes:.

ADVERTISEMENT

Image credit: Shutterstock.com

Prev

Health care organizations have to take better care of their employees

February 21, 2019 Kevin 3
…
Next

The culture of permission in medicine

February 21, 2019 Kevin 13
…

Tagged as: Nephrology

Post navigation

< Previous Post
Health care organizations have to take better care of their employees
Next Post >
The culture of permission in medicine

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • How social media leads to a loss of creativity

    Edwin Leap, MD
  • An innovative approach to fix the generic drug shortage

    Christopher Johnson, MD
  • Patient autonomy in times of shortage

    Deepak Gupta, MD
  • We are on the brink of a crisis-level physician shortage in the United States

    Jamie Katuna
  • Why the baby formula shortage happened

    Divya Srinivasan and Tejas Sekhar
  • International medical graduates ease the U.S. doctor shortage

    G. Richard Olds, MD

More in Meds

  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A shortage of Kayexalate leads to an ER visit
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...